Axon Enterprise, Inc $AXON Stock: Asset Dedication LLC Increases Position

Asset Dedication LLC lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 22,054.0% in the third quarter, Holdings Channel.com reports. The institutional investor owned 30,351 shares of the biotechnology company’s stock after purchasing an additional 30,214 shares during the quarter. Axon Enterprise makes up 0.8% of Asset Dedication LLC’s portfolio, making the stock its 17th largest holding. Asset Dedication LLC’s holdings in Axon Enterprise were worth $12,824,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of AXON. MassMutual Private Wealth & Trust FSB raised its stake in shares of Axon Enterprise by 122,993.6% during the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 461,601 shares of the biotechnology company’s stock worth $195,036,000 after buying an additional 461,226 shares during the period. B. Metzler seel. Sohn & Co. AG purchased a new stake in Axon Enterprise in the second quarter worth approximately $3,854,000. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Axon Enterprise in the first quarter worth approximately $15,067,000. Brown Lisle Cummings Inc. grew its holdings in shares of Axon Enterprise by 97,231.4% during the 2nd quarter. Brown Lisle Cummings Inc. now owns 34,066 shares of the biotechnology company’s stock worth $19,098,000 after purchasing an additional 34,031 shares during the period. Finally, Harel Insurance Investments & Financial Services Ltd. grew its stake in Axon Enterprise by 40.7% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 15,083 shares of the biotechnology company’s stock worth $6,406,000 after acquiring an additional 4,360 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have commented on AXON. The Goldman Sachs Group decreased their price objective on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a report on Monday, September 21st. Barclays boosted their price target on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Citigroup reiterated a “market outperform” rating on shares of Axon Enterprise in a research report on Monday. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Tuesday. Finally, Needham & Company LLC lowered their price target on shares of Axon Enterprise from $750.00 to $500.00 and set a “buy” rating on the stock in a report on Friday. Thirteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $631.35.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q3 revenue reached a record $909 million, up 28% year over year, while software and services revenue rose 43%. Axon also reported AI annual recurring revenue above $100 million, signaling continued demand for its software and AI offerings. Axon Q3 results
• Neutral Sentiment: Axon committed an additional $1.2 billion to drone maker Skydio, bringing its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The move could expand Axon’s Drone as First Responder business, but its scale also raises investment and execution risks. Reuters: Axon invests in Skydio
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of $908.55 million fell short of analyst expectations. Axon’s 2026 revenue forecast was reduced to $3.6 billion from a consensus of about $3.7 billion; its Q4 revenue guidance also came in below estimates. The company cited delays in federal counter-drone projects, while margin pressure added to concerns. Zacks: Q3 miss and outlook
• Negative Sentiment: Several analysts lowered price targets after the results, and Craig Hallum downgraded AXON from Buy to Hold, adding to pressure on investor sentiment. Benzinga: analyst forecast changes
• Negative Sentiment: A class-action lawsuit over Axon’s license-plate surveillance practices is a potential additional legal and reputational overhang. Class-action announcement

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $313.00 on Friday. The company has a 50 day moving average price of $441.53 and a 200 day moving average price of $475.20. The stock has a market capitalization of $25.43 billion, a P/E ratio of 100.32, a PEG ratio of 8.09 and a beta of 1.48. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. Axon Enterprise, Inc has a fifty-two week low of $307.00 and a fifty-two week high of $665.07.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). The firm had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The business’s revenue for the quarter was up 27.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.17 earnings per share. Equities research analysts forecast that Axon Enterprise, Inc will post 2.10 EPS for the current year.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the transaction, the president directly owned 296,974 shares in the company, valued at approximately $170,590,774.82. This trade represents a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the sale, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 37,397 shares of company stock valued at $21,234,034. 4.20% of the stock is currently owned by company insiders.

Axon Enterprise Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals.

The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Founded in 1993 as TASER International, the company adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into connected devices and software.